Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.0Revenue $M158Net Margin (%)-36.9Altman Z-Score-3.8
Enterprise Value $M28.4EPS $-4.5Operating Margin %-36.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-8.4Pre-tax Margin (%)-36.9Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.4Cash flow > EarningsY
Price/Sales0.25-y EBITDA Growth Rate %--Current Ratio0.7Lower Leverage y-yY
Price/Free Cash Flow3.7y-y EBITDA Growth Rate %--ROA % (ttm)-83.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-307.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M13.7ROIC % (ttm)-234.0Gross Margin Increase y-yN

Gurus Latest Trades with MSLP

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MSLP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MSLP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lupo Andrew JDirector 2014-11-24Buy16,010$10.62-82.2view
Greenwell James JCOO 2014-11-20Buy1,000$9.9-80.91view
Pyatt Brad JCEO 2014-11-20Buy9,900$10.09-81.27view
Lupo Andrew JDirector 2014-11-20Buy2,200$10.1-81.29view
MACOSKO GREGORYDirector 2014-09-19Buy1,000$13.21-85.69view
Pyatt Brad JCEO 2014-09-05Buy500$13.6-86.1view
Pyatt Brad JCEO 2014-08-22Buy5,358$12.15-84.44view
Pyatt Brad JCEO 2014-08-14Buy2,500$11.48-83.54view
Pyatt Brad JCEO 2014-08-08Buy15,000$11.27-83.23view
Greenwell James JCOO 2014-08-08Buy1,000$11-82.82view

Press Releases about MSLP :

Quarterly/Annual Reports about MSLP:

News about MSLP:

Articles On GuruFocus.com
Is MusclePharm Corp going to have a bright future or will it fail? Jul 06 2015 
MusclePharm: Fast Growing Small-Cap With 100%+ Upside Potential Jun 06 2014 

More From Other Websites
MUSCLEPHARM CORP Files SEC form 8-K, Other Events Feb 12 2016
MusclePharm Focused on Expanding Market Share in Growing Protein Sector Jan 19 2016
MusclePharm Completes $10 Million Financing Jan 14 2016
MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD... Jan 14 2016
MUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 06 2016
MusclePharm Corp. Earnings Analysis: Q3, 2015 By the Numbers Dec 11 2015
MusclePharm Executive Chairman Issues Letter to Shareholders Dec 10 2015
MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Dec 10 2015
MUSCLEPHARM CORP Financials Dec 08 2015
MUSCLEPHARM CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 17 2015
MusclePharm to Explore Sale of Its BioZone Laboratories Nevada Subsidiary’s Business Nov 17 2015
MusclePharm Reports 2015 Third Quarter Financial Results Nov 09 2015
MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of... Nov 09 2015
MusclePharm Schedules 2015 Third Quarter Financial Results Nov 05 2015
MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Oct 16 2015
Hynes Keller & Hernandez, LLC Announces Investigations of AAC Holdings, Inc., Muscle Pharm Corp.,... Sep 23 2015
MUSCLEPHARM CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Sep 08 2015
MusclePharm Corp. Statement on SEC Settlement Sep 08 2015
MusclePharm Corp. Earnings Q2, 2015 Sep 04 2015
MUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Sep 01 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK